Cita APA

Saqrane, S., El Mhammedi, M., Lahrich, S., Laghrib, F., El Bouabi, Y., Farahi, A., & Bakasse, M. (2021). Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections. J Infect Public Health.

Citación estilo Chicago

Saqrane, S., M.A El Mhammedi, S. Lahrich, F. Laghrib, Y. El Bouabi, A. Farahi, y M. Bakasse. "Recent Knowledge in Favor of Remdesivir (GS-5734) As a Therapeutic Option for the COVID-19 Infections." J Infect Public Health 2021.

Cita MLA

Saqrane, S., et al. "Recent Knowledge in Favor of Remdesivir (GS-5734) As a Therapeutic Option for the COVID-19 Infections." J Infect Public Health 2021.